Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA clears 2 new devices, grants breakthrough designation to AI model | Mitral annulus calcification & valve disease
Thursday, June 2, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Regulatory Roundup: FDA clears 2 new devices, grants breakthrough designation to advanced AI model

Catch up on several recent FDA announcements, including an update on the agency's response to the COVID-19 pandemic. 

READ MORE >
Abbott’s FreeStyle Libre 3 glucose monitor gains FDA clearance
Share on Twitter Share on Facebook Share on Linkedin

Regulatory Roundup: FDA clears 2 new devices, grants breakthrough designation to advanced AI model

Share on Twitter Share on Facebook Share on Linkedin
Abbott’s FreeStyle Libre 3 glucose monitor gains FDA clearance
Catch up on several recent FDA announcements, including an update on the agency's response to the COVID-19 pandemic. 
READ MORE >

Mitral annulus calcification more than doubles a patient’s risk of heart valve disease

"For clinicians, suspicion for valve diseases should be increased and evaluations carefully performed for patients with MAC," according to one Mayo Clinic cardiologist.

READ MORE >
Examples of mitral annulus calcification (MAC) visualized using echocardiography. Image from the journal Echocardiography.
Share on Twitter Share on Facebook Share on Linkedin

Mitral annulus calcification more than doubles a patient’s risk of heart valve disease

Share on Twitter Share on Facebook Share on Linkedin
Examples of mitral annulus calcification (MAC) visualized using echocardiography. Image from the journal Echocardiography.
"For clinicians, suspicion for valve diseases should be increased and evaluations carefully performed for patients with MAC," according to one Mayo Clinic cardiologist.
READ MORE >

Featured Articles

Survival on the rise among high-risk pulmonary embolism patients

The study's authors examined data from more than 1.4 million patients, noting that pulmonary embolism response teams appear to be playing a significant role. 

READ MORE >
Survival on the rise among high-risk pulmonary embolism patients.
Share on Twitter Share on Facebook Share on Linkedin

Survival on the rise among high-risk pulmonary embolism patients

Share on Twitter Share on Facebook Share on Linkedin
Survival on the rise among high-risk pulmonary embolism patients.
The study's authors examined data from more than 1.4 million patients, noting that pulmonary embolism response teams appear to be playing a significant role. 
READ MORE >

EHR alerts boost care for patients with HFrEF

Simple EHR alerts helped one health system get more guideline-recommended medications to its heart failure patients.

READ MORE >
Tablet projecting metaphorical medical hologram
Share on Twitter Share on Facebook Share on Linkedin

EHR alerts boost care for patients with HFrEF

Share on Twitter Share on Facebook Share on Linkedin
Tablet projecting metaphorical medical hologram
Simple EHR alerts helped one health system get more guideline-recommended medications to its heart failure patients.
READ MORE >

In Case You Missed It

VIDEO: Contrast media shortage impacting cardiac CT imaging

Eric Williamson, MD, president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, explains how the iodine contrast shortage is causing issues for cardiac CT imaging and ways this can be mitigated.

READ MORE >
Eric Williamson, MD, MSCCT, the president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, explains how the iodine contrast shortage is causing issues for cardiac CT imaging. He discusses ways imagers can stretch they iodine contrast supplies and some technologies that might help conserve contrast. #contrastshortage
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Contrast media shortage impacting cardiac CT imaging

Share on Twitter Share on Facebook Share on Linkedin
Eric Williamson, MD, MSCCT, the president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, explains how the iodine contrast shortage is causing issues for cardiac CT imaging. He discusses ways imagers can stretch they iodine contrast supplies and some technologies that might help conserve contrast. #contrastshortage
Eric Williamson, MD, president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, explains how the iodine contrast shortage is causing issues for cardiac CT imaging and ways this can be mitigated.
READ MORE >

Empagliflozin may reverse vascular aging, lower CVD risk

The SGLT2 inhibitor is already known as an effective medication for both type 2 diabetes and heart failure.

READ MORE >
heart_body_blood_bloodvessel.jpg
Share on Twitter Share on Facebook Share on Linkedin

Empagliflozin may reverse vascular aging, lower CVD risk

Share on Twitter Share on Facebook Share on Linkedin
heart_body_blood_bloodvessel.jpg
The SGLT2 inhibitor is already known as an effective medication for both type 2 diabetes and heart failure.
READ MORE >

In Other News

4 increasingly common uses for imaging AI in the ED

As FDA-approved AI software continues to proliferate in radiology—well more than 150 products to date and rising—a trio of Yale radiologists has compiled a status report focused on AI applications available to, specifically, emergency radiology.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

4 increasingly common uses for imaging AI in the ED

Share on Twitter Share on Facebook Share on Linkedin
As FDA-approved AI software continues to proliferate in radiology—well more than 150 products to date and rising—a trio of Yale radiologists has compiled a status report focused on AI applications available to, specifically, emergency radiology.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme